close
close
Baudax Bio Stock Price

Baudax Bio Stock Price

Baudax Bio Stock Price. The consensus estimate for baudax bio’s bottom line has narrowed from a loss of $15.73 to a loss of $2.91 per share, while that for 2023 has narrowed from a loss of $10.49 per share to a loss of. Zacks investment research upgraded shares of baudax bio from a.

Baudax Bio Stock PriceBaudax Bio Stock Price
BXRX Stock Price and Chart — NASDAQBXRX — TradingView from www.tradingview.com

Bxrx shares fell 17.2% to close at $1.44 following downbeat quarterly results. The consensus estimate for baudax bio’s bottom line has narrowed from a loss of $15.73 to a loss of $2.91 per share, while that for 2023 has narrowed from a loss of $10.49 per share to a loss of. Although market cap metrics of such companies may seem unimpressive, you shouldn't immediately discard them.

(Nasdaq:bxrx), A Pharmaceutical Company Focused On Commercializing And Developing Innovative Products For Acute Care Settings.

1 day agothe company’s fifty day moving average price is $4.95 and its 200 day moving average price is $7.00. A number of equities analysts have recently commented on the stock. Bxrx shares fell 17.2% to close at $1.44 following downbeat quarterly results.

The Consensus Estimate For Baudax Bio’s Bottom Line Has Narrowed From A Loss Of $15.73 To A Loss Of $2.91 Per Share, While That For 2023 Has Narrowed From A Loss Of $10.49 Per Share To A Loss Of.

Etsy fell 16.8% to close. Zacks investment research upgraded shares of baudax bio from a. Although market cap metrics of such companies may seem unimpressive, you shouldn't immediately discard them.

Aptevo Therapeutics Has A 1 Year Low Of $3.45 And A 1 Year High Of $31.76.

Zeta dropped 16.9% to close at $8.64. Stocks of companies with small market cap — us stock market.

Leave a Reply

Your email address will not be published. Required fields are marked *